National Health Investors (NYSE:NHI) Reaches New 12-Month Low - Time to Sell?

Key Points

• National Health Investors shares hit a new 52-week low, trading as low as $64.51 and recently near $65, below both the 50-day and 200-day moving averages.
• Analysts maintain a generally favorable outlook, with five Buy ratings and four Holds; the consensus rating is “Moderate Buy” and the average price target is $82.25.
• NHI reported $1.19 in quarterly EPS on $121.32 million in revenue, while its $0.92 quarterly dividend implies a 5.6% yield; however, the payout ratio is elevated at 108.67%.

National Health Investors, Inc. (NYSE:NHI - Get Free Report) shares hit a new 52-week low on Tuesday. The company traded as low as $64.51 and last traded at $65.0710, with a volume of 20610 shares trading hands. The stock had previously closed at $65.02.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on NHI. BMO Capital Markets restated an "outperform" rating on shares of National Health Investors in a research report on Wednesday, September 23rd. National Bank Financial set a $79.00 price target on National Health Investors in a report on Wednesday, September 9th. Wells Fargo & Company decreased their price objective on shares of National Health Investors from $79.00 to $78.00 and set an "equal weight" rating for the company in a report on Tuesday, September 1st. Deutsche Bank Aktiengesellschaft lowered their target price on National Health Investors from $85.00 to $80.00 and set a "hold" rating for the company in a research note on Thursday, June 25th. Finally, Huntington assumed coverage on shares of National Health Investors in a research note on Thursday, September 10th. They set an "outperform" rating and a $79.00 price objective on the stock. Five research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company's stock. According to MarketBeat, National Health Investors has an average rating of "Moderate Buy" and an average price target of $82.25.

National Health Investors Price Performance

The company has a current ratio of 6.78, a quick ratio of 6.78 and a debt-to-equity ratio of 0.81. The firm has a fifty day moving average of $71.30 and a 200 day moving average of $75.35. The company has a market capitalization of $3.21 billion, a P/E ratio of 18.92, a P/E/G ratio of 3.51 and a beta of 0.49.

National Health Investors (NYSE:NHI - Get Free Report) last issued its quarterly earnings data on Monday, August 10th. The real estate investment trust reported $1.19 earnings per share for the quarter. The company had revenue of $121.32 million for the quarter. National Health Investors had a net margin of 38.56% and a return on equity of 10.89%. The firm's revenue for the quarter was up 1.6% on a year-over-year basis. During the same quarter last year, the company earned $1.22 EPS. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. On average, equities research analysts anticipate that National Health Investors, Inc. will post 4.76 EPS for the current year.

National Health Investors Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 6th. Stockholders of record on Wednesday, September 30th will be paid a $0.92 dividend. This represents a $3.68 annualized dividend and a dividend yield of 5.6%. The ex-dividend date is Wednesday, September 30th. National Health Investors's dividend payout ratio is 108.67%.

Hedge Funds Weigh In On National Health Investors

Several institutional investors and hedge funds have recently bought and sold shares of the stock. Versant Capital Management Inc lifted its position in shares of National Health Investors by 108.5% during the 3rd quarter. Versant Capital Management Inc now owns 415 shares of the real estate investment trust's stock valued at $27,000 after buying an additional 216 shares in the last quarter. Allworth Financial LP bought a new stake in shares of National Health Investors in the second quarter worth about $42,000. EverSource Wealth Advisors LLC grew its holdings in National Health Investors by 34.3% during the 1st quarter. EverSource Wealth Advisors LLC now owns 626 shares of the real estate investment trust's stock valued at $51,000 after buying an additional 160 shares in the last quarter. Field & Main Bank purchased a new stake in National Health Investors during the second quarter valued at $76,000. Finally, Rockefeller Capital Management L.P. increased its holdings in shares of National Health Investors by 80.6% in the 4th quarter. Rockefeller Capital Management L.P. now owns 1,022 shares of the real estate investment trust's stock worth $78,000 after buying an additional 456 shares during the last quarter. 62.51% of the stock is currently owned by hedge funds and other institutional investors.

National Health Investors Company Profile

National Health Investors, Inc NYSE: NHI is a self-managed real estate investment trust that owns and finances healthcare-related real estate. The company primarily invests in properties used by seniors and patients, including senior housing communities, skilled nursing facilities, medical office buildings and other healthcare facilities.

NHI generally leases its properties to healthcare operators under long-term agreements and may provide mortgage or other financing to support the development and operation of healthcare real estate.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.